Molecular Biotechnology 2012-02-01

Overexpression of cinnamate 4-hydroxylase gene enhances biosynthesis of decursinol angelate in Angelica gigas hairy roots.

Nam Il Park, Jee Hee Park, Sang Un Park

Index: Mol. Biotechnol. 50(2) , 114-20, (2012)

Full Text: HTML

Abstract

Angelica gigas is a medicinal plant that produces pyranocoumarins, including decursin (D) and decursinol angelate (DA), which have neuroprotective, anticancer, and antiandrogenic effects. In this study, the coumarin biosynthetic pathway was engineered to increase the production of DA. Specifically, a vector was constructed which contained the A. gigas phenylalanine ammonia-lyase (AgPAL) and cinnamate 4-hydroxylase (AgC4H) genes that were driven by the cauliflower mosaic virus (CaMV) 35S promoter. Transgenic hairy roots that overexpressed AgPAL or AgC4H genes were obtained by using an Agrobacterium rhizogenes-mediated transformation system. Among them, only AgC4H-transgenic hairy root lines produced more DA than control transgenic hairy root lines. The enhanced gene expression corresponded to elevated C4H activities. This study showed the importance of C4H in the production of DA in A. gigas hairy root culture.


Related Compounds

Related Articles:

Decursin attenuates hepatic fibrogenesis through interrupting TGF-beta-mediated NAD(P)H oxidase activation and Smad signaling in vivo and in vitro.

2014-07-17

[Life Sci. 108(2) , 94-103, (2014)]

Ultrafine Angelica gigas powder normalizes ovarian hormone levels and has antiosteoporosis properties in ovariectomized rats: particle size effect.

2012-10-01

[J. Med. Food 15(10) , 863-72, (2012)]

Inhibition of angiogenic attributes by decursin in endothelial cells and ex vivo rat aortic ring angiogenesis model.

2011-11-01

[Indian J. Exp. Biol. 49(11) , 848-56, (2011)]

Decursin exerts anti-cancer activity in MDA-MB-231 breast cancer cells via inhibition of the Pin1 activity and enhancement of the Pin1/p53 association.

2014-02-01

[Phytother Res. 28(2) , 238-44, (2014)]

Biopharmaceutical characterization of decursin and their derivatives for drug discovery.

2013-10-01

[Drug Dev. Ind. Pharm. 39(10) , 1523-30, (2013)]

More Articles...